Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

Publication | Closed Access

DOI

Citations

References

2011

Year

Gianfranco Pesce, Dirk Klingbiel, Karin Ribi, Abderahim Zouhair, Roger von Moos, Marc Schlaeppi, Clemens B. Caspar, Natalie Fischer, Sandro Anchisi, Solange Peters,

European Journal of Cancer

Neuro-oncologyRadiation TherapyMedicineCancer ManagementSakk 70/03Cognitive FunctionWhole Brain RadiotherapyCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchRadiologyHealth Sciences